Almanack Investment Partners’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-188
Closed -$4K 633
2022
Q3
$4K Buy
+188
New +$4.41K ﹤0.01% 626

Other funds holding IBD

Almanack Investment Partners's IBD Position: Q4 2022 in Review

Almanack Investment Partners sold out of Inspire Corporate Bond ETF (IBD) in Q4 2022, closing a stake of 188 shares — an estimated $4K sold.

Almanack Investment Partners first reported a position in IBD in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 51 funds tracked by Wall St. Rank hold IBD as of Q4 2022.

  • Almanack Investment Partners reported no remaining Inspire Corporate Bond ETF position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 188 Inspire Corporate Bond ETF shares in Q4 2022, an estimated $4K.
  • Almanack Investment Partners first reported a position in Inspire Corporate Bond ETF in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Inspire Corporate Bond ETF position peaked at $4K in Q3 2022.
  • 51 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.